Conner Feldman

Strategy Manager, Emerging Modalities

Conner is the strategy manager for emerging modalities. He is responsible for the strategy development and positioning of the mRNA analytical development and biosafety testing portfolio.

He holds a B.S. in genetics from the University of Wisconsin-Madison and an MBA in strategy and leadership from Indiana University Kelley School of Business.

On demand Webinar mRNA – POWERING LIFE CHANGING THERAPIES

In this webinar, join industry experts to learn about strategies to accelerate mRNA therapies and enable scalability and process efficiency from preclinical to commercial.

Scroll to Top